カテゴリ： MarketLine, スロベニア, 企業調査

Terme Dobrna D.D.：企業の戦略・SWOT・財務分析

◆英語タイトル：Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3338
◆発行会社（調査会社）：MarketLine
◆発行日：2019年11月
◆ページ数：23
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スロベニア
◆産業分野：Leisure and Arts
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Terme Dobrna D.D. – Strategy, SWOT and Corporate Finance Report
Summary

Terme Dobrna D.D. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Terme Dobrna d.d. (Terme Dobrna) operates luxury hotels, apartments and campsites. The company’s four-star hotel properties include Hotel Vita, Hotel Depandance Vila Higiea and Hotel Park. The company’s hotels offers accommodation services through single rooms, double rooms, triple rooms and executive suites. It also comprises various facilities, such as, meeting restaurants, pub, sport and action, spa, swimming pool and entertainment. The company also offers meeting rooms for conferences and events. Terme Dobrna offers medical and wellness services through its, outpatient centers, rehabilitation centers and spas. The company also provides adventures programs and catering services. Terme Dobrna is headquartered in Dobrna, Slovenia.

Scope

- Detailed information on Terme Dobrna D.D. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Terme Dobrna D.D. in the form of a SWOT analysis
- An in-depth view of the business model of Terme Dobrna D.D. including a breakdown and examination of key business segments
- Intelligence on Terme Dobrna D.D.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Terme Dobrna D.D., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Terme Dobrna D.D. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Terme Dobrna D.D. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Terme Dobrna D.D.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Terme Dobrna d.d.: Company Overview
Terme Dobrna d.d.: Overview and Key Facts
Terme Dobrna d.d.: Overview
Terme Dobrna d.d.: Key Facts
Terme Dobrna d.d.: Key Employees
Terme Dobrna d.d.: Major Products and Services
Terme Dobrna d.d.: Company History
Terme Dobrna d.d.: Management Statement
Terme Dobrna d.d.: Key Competitors
Terme Dobrna d.d.: Company Analysis
Terme Dobrna d.d.: Business Description
Terme Dobrna d.d.: SWOT Analysis
Terme Dobrna d.d.: SWOT Overview
Terme Dobrna d.d.: Strengths
Terme Dobrna d.d.: Weaknesses
Terme Dobrna d.d.: Opportunities
Terme Dobrna d.d.: Threats
Terme Dobrna d.d.: Corporate Financial Deals Activity
Terme Dobrna d.d.: Financial Deals Overview
Terme Dobrna d.d.: Top Deals 2015 – 2019YTD*
Terme Dobrna d.d.: Private Equity and Ownership
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Terme Dobrna d.d.: Key Facts
Table 2: Terme Dobrna d.d.: Key Employees
Table 3: Terme Dobrna d.d.: Company History
Table 4: Terme Dobrna d.d.: Key Competitors
Table 5: Terme Dobrna d.d.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 6: Terme Dobrna d.d.: Top Deals 2015 - 2019YTD*
Table 7: Terme Dobrna d.d.: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 8: Terme Dobrna d.d.: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Terme Dobrna D.D.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • GE Energy：戦略・SWOT・企業財務分析
    GE Energy - Strategy, SWOT and Corporate Finance Report Summary GE Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The Buckle, Inc.：企業の戦略・SWOT・財務情報
    The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Elecnor SA (ENO)：企業の財務・戦略的SWOT分析
    Elecnor SA (ENO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioScrip Inc (BIOS)-医療機器分野：企業M&A・提携分析
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that offers infusion care services. The hospital provides a range of infusion services, PBM services and respiratory services. Its infusion therapy services include antimicrobial drugs, factor replacement therapy for …
  • Sony Mobile Communications AB.：企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Innovative Solutions and Support, Inc.：企業の戦略・SWOT・財務分析
    Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report Summary Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • METRO Retail Stores Group Inc (MRSGI)：企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Bank of Ayudhya Public Co Ltd (BAY)：企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Carr’s Group Plc (CARR)：企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Halozyme Therapeutics Inc (HALO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • ARMO Biosciences Inc：企業のM&A・事業提携・投資動向
    ARMO Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ARMO Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Inotek Pharmaceuticals Corp (RCKT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …
  • Link Healthcare Pty Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Link Healthcare Pty Ltd (LINK), a subsidiary of Clinigen Group Plc, is a healthcare solution provider that provides generic products. The company offers therapeutic products, prescription, OTC medicines and medical devices in various therapeutic areas. It offers products such as relistor, an …
  • TWC Enterprises Limited：企業の戦略・SWOT・財務情報
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Franklin Covey Co. (FC)：企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Prescient Therapeutics Ltd (PTX)：企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the …
  • Advint, LLC：企業の戦略・SWOT・財務情報
    Advint, LLC - Strategy, SWOT and Corporate Finance Report Summary Advint, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Care Group：企業の製品パイプライン分析2018
    Summary Care Group India (Care Group) is a manufacturer and supplier of intraocular lens (IOLs) and ophthalmic surgical products. Its product portfolio includes cataract intraocular lens (IOLs) including hydrophilic, hydrophobic, polymethyl methacrylate (PMMA) models and implantable phakic contact l …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)：医療機器：M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Atrium Innovations Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆